Issue Information – Table of Contents
Conventional cytogenetics for myeloid neoplasms in the era of next‐generation‐sequencing
Simple matters in complex times
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double‐induction chemotherapy
Poor outcomes associated with +der(22)t(9;22) and −9/9p in patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor
Lenalidomide and low‐dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients
Increased healthcare use up to 10 years among relapse‐free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft‐versus host disease after stem‐cell transplantation from unrelated donors
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide‐dexamethasone therapy in multiple myeloma
Significance of recurrence of minimal residual disease detected by multi‐parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
Pure erythroid leukemia
Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS‐T)
Circulating lymphoma cells in intravascular large B‐cell lymphoma
Sepsis and persisting neutropenia in a drug addict
Diagnostic work‐up of acute myeloid leukemia
Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus
Diffuse pulmonary extramedullary hematopoiesis in myelofibrosis diagnosed with technetium‐99m sulfur colloid bone marrow scintigraphy and single photon emission computerized tomography/CT
The heterozygote state for β‐thalassemia detrimentally affects health outcomes
Myelolipoma among patients with thalassemia major and rare anemia with iron loading
Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes
EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
Thrombospondin‐1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia
Idarucizumab for urgent reversal of dabigatran for heart transplant
Serum ferritin values between 300 and 800 ng/mL in nontransfusion‐dependent thalassemia